Provided by Tiger Fintech (Singapore) Pte. Ltd.

Kiora Pharmaceuticals

2.99
-0.0600-1.97%
Post-market: 3.100.1098+3.67%16:40 EDT
Volume:31.48K
Turnover:95.59K
Market Cap:9.10M
PE:-1.04
High:3.10
Open:3.10
Low:2.99
Close:3.05
Loading ...
Jul 13, 2022

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Jul 08, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 07, 2022

[Rev.]Annual Report

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
Jun 21, 2022

Major Issues Report

8-K - Current report
May 31, 2022

Major Issues Report

8-K - Current report
May 23, 2022

Major Issues Report

8-K - Current report
May 03, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
May 03, 2022

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Apr 26, 2022

Major Issues Report

8-K - Current report
Apr 15, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 23, 2022

Major Issues Report

8-K - Current report
Feb 28, 2022

Major Issues Report

8-K - Current report
Feb 15, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Major Issues Report

8-K - Current report
Feb 11, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 01, 2022

Major Issues Report

8-K - Current report
Jan 27, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 24, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 11, 2022

Major Issues Report

8-K - Current report
Dec 15, 2021

Major Issues Report

8-K - Current report